Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use
A careful review can determine whether B12 alone is enough or whether a broader nutrient strategy is more appropriate
Detailed Product Description 5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration
TREATMENT LENGTH A fast, comfortable 5-minute intramuscular (IM) injection
16 The needle is inserted along the inferior medial border of the scapula and directed parallel to the plane of the undersurface of the scapula, not toward the chest wall (Figure 4)
It has a range of syringes and needles for varied purposes